{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:07:08Z","timestamp":1750133228450,"version":"3.41.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Primary cutaneous gamma delta T-cell lymphoma (PCGDTCL) is a rare type of non-Hodgkin lymphoma accounting for &lt;1% of primary cutaneous T-cell lymphomas. The exact cause of PCGDTCL is not known, however, it is thought that chronic antigen exposure in the skin may lead to immune dysregulation at the site, resulting in abnormal proliferation of mature, post-thymic cytotoxic gamma delta T cells. Mutations are the most common genetic alteration seen in PCGDTCL, while structural abnormalities such as gene fusions are not common. We report a case of PCGDTCL with atypical immunophenotypic features, including expression of CD5 with lack of cytotoxic marker expression, and a structural alteration leading to <jats:italic toggle=\"yes\">FYN<\/jats:italic> deletion at exon 8. Recently, it was described that a deletion of the area between <jats:italic toggle=\"yes\">FYN<\/jats:italic> exon 8 and <jats:italic toggle=\"yes\">TRAF3IP2<\/jats:italic> intron 2 results in a novel <jats:italic toggle=\"yes\">FYN::TRAF3IP2<\/jats:italic> fusion in peripheral T-cell lymphoma, not otherwise specified. We describe our patient's clinical course, differential diagnosis, and potential implications of <jats:italic toggle=\"yes\">FYN<\/jats:italic> deletion on disease pathogenesis. To our knowledge, this is the first report of an <jats:italic toggle=\"yes\">FYN<\/jats:italic> structural alteration to be described in PCGDTCL.<\/jats:p>","DOI":"10.1097\/dad.0000000000002856","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T14:00:08Z","timestamp":1729087208000},"page":"e120-e123","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Rapidly Progressive Primary Cutaneous Gamma Delta T-Cell Lymphoma With FYN Gene Alteration"],"prefix":"10.1097","volume":"46","author":[{"given":"Mahzad","family":"Azimpouran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chau M.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Balzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5683-4077","authenticated-orcid":false,"given":"Sumire","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nat Commun"},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2015.01.003","article-title":"Hematopoietic stem cell transplantation for primary cutaneous \u03b3\u03b4 T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma","volume":"72","author":"Gibson","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/bjd.17985","article-title":"Epidemiology of primary cutaneous \u03b3\u03b4 T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the U.S.A. from 2006 to 2015: a Surveillance, Epidemiology, and End Results-18 analysis","volume":"181","author":"Goyal","year":"2019","journal-title":"Br J Dermatol"},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jamadermatol.2016.3117","article-title":"Cutaneous gamma-delta T-cell lymphoma successfully treated with brentuximab vedotin","volume":"152","author":"Rubio-Gonzalez","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/PAS.0000000000000768","article-title":"Primary cutaneous T-cell lymphomas showing gamma-delta (\u03b3\u03b4) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous \u03b3\u03b4 T-cell lymphomas","volume":"41","author":"Merrill","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.path.2021.03.001","article-title":"Gamma\/delta phenotype in primary cutaneous T-cell lymphomas and lymphoid proliferations: challenges for diagnosis and classification","volume":"14","author":"Torres-Cabala","year":"2021","journal-title":"Surg Pathol Clin"},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bjd.13364","article-title":"\u03b3\u03b4 T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous \u03b3\u03b4 T-cell lymphomas","volume":"172","author":"Martinez-Escala","year":"2015","journal-title":"Br J Dermatol"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0560.2011.01859.x","article-title":"Expression of T-cell receptor-\u03b3\u03b4 in normal human skin, inflammatory dermatoses and mycosis fungoides","volume":"39","author":"Hocker","year":"2012","journal-title":"J Cutan Pathol"},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/cup.14063","article-title":"Gamma\/delta T-cell lymphoma with mycosis fungoides-like clinical course transforming to \"T-cell-receptor-silent\" aggressive lymphoma: description of one case","volume":"48","author":"Tomasini","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jaad.2020.10.012","article-title":"Diagnosis of gamma\/delta mycosis fungoides requires longitudinal clinical observation","volume":"85","author":"Ferrier","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/DAD.0000000000000029","article-title":"Two cases of primary cutaneous lymphoma with a \u03b3\/\u03b4+ phenotype and an indolent course: further evidence of heterogeneity of cutaneous \u03b3\/\u03b4+ T-cell lymphomas","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jdcr.2019.01.009","article-title":"\u03b3\u03b4 lymphomatoid papulosis type D: A histologic mimic of primary cutaneous \u03b3\u03b4 T-cell lymphoma","volume":"5","author":"Badje","year":"2019","journal-title":"JAAD Case Rep"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PAS.0000000000002200","article-title":"Lymphomatoid papulosis with T-cell receptor-gamma delta expression: a clinicopathologic case-series of 26 patients of an underrecognized immunophenotypic variant of lymphomatoid papulosis","volume":"48","author":"Mark","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3324\/haematol.2020.262659","article-title":"CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)","volume":"106","author":"Maura","year":"2021","journal-title":"Haematologica"},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"13637","DOI":"10.1007\/s13277-016-5259-8","article-title":"Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides","volume":"37","author":"Garaicoa","year":"2016","journal-title":"Tumour Biol"},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjd.13476","article-title":"Diagnostic and prognostic significance of CDKN2A\/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease","volume":"172","author":"Nicolae-Cristea","year":"2015","journal-title":"Br J Dermatol"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.3390\/cancers14205152","article-title":"Genetic stability of driver alterations in primary cutaneous diffuse large B-cell lymphoma, leg type and their relapses: a rationale for the use of molecular-based methods for more effective disease monitoring","volume":"14","author":"Schrader","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/dermatopathology8040054","article-title":"Primary cutaneous gamma-delta T cell lymphomas: a case series and overview of the literature","volume":"8","author":"Alberti-Violetti","year":"2021","journal-title":"Dermatopathology (Basel)"},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s43018-020-00161-w","article-title":"FYN-TRAF3IP2 induces NF-\u03baB signaling-driven peripheral T cell lymphoma","volume":"2","author":"Moon","year":"2021","journal-title":"Nat Cancer"},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1038\/s41467-021-24037-4","article-title":"Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified","volume":"12","author":"Debackere","year":"2021","journal-title":"Nat Commun"},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.24203","article-title":"A three-signal model of T-cell lymphoma pathogenesis","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/biomedicines6020038","article-title":"NF-\u03baB activation in lymphoid malignancies: genetics, signaling, and targeted therapy","volume":"6","author":"Grondona","year":"2018","journal-title":"Biomedicines"},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood.2021012536","article-title":"Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway","volume":"138","author":"Lee","year":"2021","journal-title":"Blood"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:02:56Z","timestamp":1750096976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002856","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"type":"print","value":"0193-1091"},{"type":"electronic","value":"1533-0311"}],"subject":[],"published":{"date-parts":[[2024,10,15]]}}}